ARDT241220C17500
- 0.18
- -0.12-40.00%
Ardent Health Partners Newsroom
Why Ardent Health Partners (ARDT) Is the Best All-Time Low Stock to Buy Right Now?
Ardent Health Partners, Inc. Positioned for Growth With Stable Regulatory Environment and Strategic Expansion: Analyst Confirms Buy Rating
Truist Financial Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Announces Target Price $22
Ardent Health Partners Insider Bought Shares Worth $339,600, According to a Recent SEC Filing
Ardent Health Partners, Inc. Achieves Q3 2024 Growth Through Strategic Service Line Expansion and Cost Management
Ardent Health Partners Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Ardent Health Partners Is Maintained at Outperform by Leerink Partners
Express News | Ardent Health Partners Inc : Leerink Partners Raises Target Price to $25 From 23
Loop Capital Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Maintains Target Price $21
Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX), 89bio (ETNB) and Ardent Health Partners, Inc. (ARDT)
RBC Capital Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Maintains Target Price $23
Ardent Health Partners, Inc.: Strong Financial Performance and Growth Potential Drive Buy Rating
Ardent Health Partners | 10-Q: Quarterly report
Ardent Health Partners Shares Are Trading Higher After the Company Raised Its FY24 Guidance.
Truist Financial Maintains Ardent Health Partners(ARDT.US) With Buy Rating
Morgan Stanley Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Maintains Target Price $27
BofA Securities Maintains Ardent Health Partners(ARDT.US) With Hold Rating, Maintains Target Price $19
Mizuho Securities Maintains Ardent Health Partners(ARDT.US) With Buy Rating
Mizuho Securities Keeps Their Buy Rating on Ardent Health Partners, Inc. (ARDT)
Press Release: Ardent Health Reports Third Quarter 2024 Results